Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
2 August 2017
On Tuesday 19th September 2017, Professor Frank Lichtenberg from Columbia University will lead an OHE Lunchtime Seminar on the topic of: How cost-effective are new cancer…
OHE at HTAi Rome
12 July 2017
The presentations delivered by OHE at the HTAi Annual Meeting, June 2017, are available in this post.
Assessing Value, Budget Impact, and Affordability in Asia
10 July 2017
A new paper, Assessing Value, Budget Impact, and Affordability in Asia, has been published in the International Journal of Technology Assessment in Health Care. This paper…
OHE at iHEA Boston 2017: Meet the Team
5 July 2017
The 2017 iHEA congress will be held in Boston, 7th-11th July 2017. Members of the OHE team will be attending and participating in the conference, and…
OHE at ISPOR Boston 2017: Presentations and Posters
4 July 2017
A selection of the posters and presentations delivered by OHE at the ISPOR 22nd Annual International Meeting in Boston, May 2017, are available below. Adrian Towse…
Adaptation to Health States: Sick Yet Better Off?
21 June 2017
OHE’s Patricia Cubi-Molla, joint with Mireia Jofre-Bonet and Victoria Serra-Sastre from City, University of London, have a new paper that examines adaptation to health states using…
OHE at HTAi 2017: Meet the Team
13 June 2017
The HTAi Annual Meeting 2017 will be held in Rome, Italy, 17-21st June 2017. The theme of the meeting is Towards an HTA Ecosystem: From Local…
Multi-criteria Decision Analysis (MCDA) to Support Healthcare Decisions: Opportunities, Challenges and Unresolved Questions
18 May 2017
Just published is a new book entitled “Multi-criteria Decision Analysis (MCDA) to Support Healthcare Decisions”. It features a chapter by OHE’s Martina Garau and Professor Nancy…
Is There Societal Support for an End of Life Premium?
8 May 2017
OHE’s Koonal Shah gave a presentation on the evidence of societal support for an end of life premium at the Pharmaccess Leaders Forum in Milan on…